UK markets closed

Anheuser-Busch InBev SA/NV (BUD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
58.11-0.72 (-1.22%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5115.17B
Enterprise value 3209.57B
Trailing P/E 20.46
Forward P/E 116.94
PEG ratio (5-yr expected) 129.44
Price/sales (ttm)2.24
Price/book (mrq)1.68
Enterprise value/revenue 34.08
Enterprise value/EBITDA 712.23

Trading information

Stock price history

Beta (5Y monthly) 1.43
52-week change 36.86%
S&P500 52-week change 332.94%
52-week high 379.67
52-week low 351.45
50-day moving average 359.75
200-day moving average 367.53

Share statistics

Avg vol (3-month) 31.52M
Avg vol (10-day) 31.41M
Shares outstanding 51.98B
Implied shares outstanding 6N/A
Float 8940.95M
% held by insiders 10.01%
% held by institutions 14.53%
Shares short (30 Aug 2021) 46.2M
Short ratio (30 Aug 2021) 44.67
Short % of float (30 Aug 2021) 4N/A
Short % of shares outstanding (30 Aug 2021) 40.31%
Shares short (prior month 29 Jul 2021) 44.17M

Dividends & splits

Forward annual dividend rate 41.17
Forward annual dividend yield 42.01%
Trailing annual dividend rate 30.61
Trailing annual dividend yield 31.04%
5-year average dividend yield 43.13
Payout ratio 421.09%
Dividend date 302 Jun 2021
Ex-dividend date 403 May 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 11.21%
Operating margin (ttm)26.79%

Management effectiveness

Return on assets (ttm)3.89%
Return on equity (ttm)9.42%

Income statement

Revenue (ttm)51.41B
Revenue per share (ttm)25.67
Quarterly revenue growth (yoy)31.50%
Gross profit (ttm)27.25B
EBITDA 17.13B
Net income avi to common (ttm)5.76B
Diluted EPS (ttm)2.84
Quarterly earnings growth (yoy)432.30%

Balance sheet

Total cash (mrq)7.08B
Total cash per share (mrq)3.57
Total debt (mrq)90.64B
Total debt/equity (mrq)113.92
Current ratio (mrq)0.65
Book value per share (mrq)34.65

Cash flow statement

Operating cash flow (ttm)13.71B
Levered free cash flow (ttm)9.75B